Grant Support

• "Use of Apraclonidine for Compassionate Adjunctive Medical Therapy in Patients with Poorly Controlled Intraocular Pressure," Kresge Eye Institute, D.H. Shin, M.D., Ph.D, Principal Investigator, Mildred M.G. Olivier, M.D., Co-Investigator Alcon Laboratories, Fort Worth, Texas, 1992 1993



• "Short Term Use of Apraclonidine in Patients on Maximum Tolerated Medical Therapy for Glaucoma," D.H. Shin, M.D., Ph.D., Principal Investigator, Mildred M.G. Olivier, M.D.,Co-Investigator Alcon Laboratories, Fort Worth Texas, 1992-1993



• "Evaluation of BID 2% Pilocarpine Ophthalmic Gel Used Adjunctively with Timoptic to Reduce Intraocular Pressure," Kresge Eye Institute, Detroit, Michigan, D.H. Shin, M.D., Ph.D. Pricipal Investigator, Mildred M.G. Olivier, M.D., Alcon Laboratories, Fort Worth, Texas, 1992-1993

• "Double Masked Multicenter C-9225 Ophthalmic Suspension - Topical Carbonic Anhydrase Dose Response Study (AL 4862)," Kresge Eye Institute, Detroit, Michigan, D.H. Shin, M.D., Ph..D, Principal Investigator, Mildred M.G. Olivier, M.D.,Co-Investigator Alcon Laboratories, Fort Worth, Texas, 1992 -1993



• A Randomized Double Masked, Multicenter Parallel Study Comparing the Effects of Carteolol Hydrochloride 1% Sterile Ophthalmic Solution on Ocular and Systemic Tolerability in Mature Black Women With Primary Open Angle Glaucoma or Ocular Hypertension Study 972-94-203, Principle Investigator, Mildred M.G. Olivier, M.D., Otsuka America Pharmaceutical, Inc., Rockville, MD 1993-1994



• A Six-Month, Triple-Masked, Parallel Group, Primary Therapy Study of the Safety and Efficacy of AL-6221 0.0015% and AL-6221 0.004% Compared to Timoptic 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension (C-97-72), Principle Investigator, Mildred M.G. Olivier, M.D., Alcon Laboratories, Fort Worth, TX 1998

Research Experience

• Fixated and dehydrated tissues (lacrimal glands) in ethanol and xylene. Embedded tissues in paraffin, cut and prepared tissues for radiolabelled antigen uptake studies. Zeiss Photoscope II fluorescence microscope used to determine the total number of IgA, IgG, and IgM RESEARCH containing cells in lacrimal glands. Mathea Allansmith, M.D., and David A. Sullivan, Ph.D., Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston Massachusetts, 1987-1988

• Retinal Ischemia. Evaluation of factors which present a role in ischemia. Norman Blair, M.D., Department of Ophthalmology, University of Illinois, Chicago, IL 1987



• Evaluation of 2085 pediatric charts in an inner city hospital for most common ophthalmic pathology, Harlem Hospital Center, New York, NY 1990